Gitanjali Srivastava

机构：Vanderbilt University, Vanderbilt University Medical Center · ORCID：0000-0002-8326-3089

发表论文 63 篇 · 总被引 1830 次 · h-index 18

代表论文

Real‐world titration, persistence & weight loss of semaglutide and tirzepatide in an academic obesity clinic (2025 · Diabetes Obesity and Metabolism · 被引 22)
Weight maintenance on cost‐effective antiobesity medications after 1 year of GLP‐1 receptor agonist therapy: a real‐world study (2024 · Obesity · 被引 20)
Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial (2024 · Nature Medicine · 被引 18)
Body Composition Changes After Bariatric Surgery or Treatment With GLP-1 Receptor Agonists (2026 · JAMA Network Open · 被引 8)
Early‐Onset Obesity and Tirzepatide Treatment: A Post Hoc Analysis of the SURMOUNT Clinical Trials (2025 · Obesity · 被引 6)
Considerations for the design and conduct of pediatric obesity pharmacotherapy clinical trials: Proceedings of expert roundtable meetings (2024 · Pediatric Obesity · 被引 5)